Fact Check: Moderna began clinical trials of COVID vaccine in 2020, not 2017
Data on mRNA vaccines sent by Moderna to European regulators before the COVID-19 outbreak included early tests of the mRNA ...
Moderna Shares Plunge After Predicting Steep 2025 Sales Decline
The company's newer product, an RSV ( respiratory syncytial virus) vaccine, has also underperformed, contributing "minimal sales" in 2024. Analysts' concerns were heightened by the company's revised ...
Yahoo Finance1mon
Moderna expects revenue of $1.5 billion to $2.5 billion in 2025
Moderna now projects $1.5 billion to $2.5 billion in revenue in 2025, mostly in the second half of the year, primarily due to the Covid-19 vaccine Spikevax.
Yahoo Finance1mon
Moderna surprises the Street by predicting a bigger-than-expected sales drop
Moderna pulled in most of its revenue last year from its COVID-19 vaccine, Spikevax, which brought in more than $3 billion in sales. Regulators also approved a Moderna vaccine for RSV, or ...
San Antonio Express-News1mon
Moderna surprises the Street by predicting a bigger-than-expected sales drop
Shares of Moderna tumbled in early trading Monday after the vaccine maker predicted a steeper-than-expected sales drop in the new year. Moderna said it expects 2025 revenue to range between $1.5 ...
WFMZ-TV1mon
Moderna surprises the Street by predicting a bigger-than-expected sales drop
FILE - A local resident receives the Moderna COVID-19 vaccine shot at a center, June 30, 2021, in the Sumida ward of Tokyo. Shares of Moderna tumbled in early trading Monday after the vaccine ...